Monogram Technologies announced that on Saturday, July 26, Monogram completed a fully autonomous saw-based robotic knee replacement procedure on a live patient. The procedure was performed at the Krishna Shalby Hospital in Ahmedabad India, as part of Monogram’s multi-center clinical trial in India for the Monogram TKA System. As previously announced, Monogram and Shalby partnered to evaluate the safety and effectiveness of the mBos TKA System with the Consensus CKS implant, which is substantially equivalent to the Monogram mPress implants for regulatory purposes. On April 29, 2025, Monogram obtained regulatory approval from India’s Central Drugs Standard Control Organization to import its mBos TKA system to conduct a multi-center clinical investigation evaluating the safety and effectiveness of the Monogram TKA System. The clinical trial includes 102 total knee replacement procedures, with a three-month clinical follow-up, conducted across multiple sites in India.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRM:
- Monogram Orthopaedics Announces Acquisition by Zimmer Biomet
- Roth MKM medical technology analyst holds analyst/industry conference call
- DoorDash, Southwest downgraded: Wall Street’s top analyst calls
- Zimmer Biomet upgraded to Buy from Neutral at Roth Capital
- Monogram Orthopaedics Ends License Agreement with Mount Sinai